Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0034186 (pyelonephritis)
 6,144 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

196 cases with vesicoureteral reflux (VUR) from multiple centers were analysed to examine the relationship between VUR and reflux nephropathy. The high correlation (p less than 0.01) was observed between reflux and renal scarring. Even in cases in whom VUR was not demonstrated at the time of testing, renal scarring of various degrees was recognized, suggesting either co-existed hypoplastic kidney or pre-existed infection. The renal scarring, but not VUR, had a significant correlation with proteinuria and hypertension. Retrospective analysis shows that the surgical treatment was closely related to the degree of renal scarring but not to the degree of reflux. Renal scarring progressed even when reflux did not become worse, which is probably accounted for by the presence of pyelonephritis. Although frequency of pyelonephritis decreased significantly (p less than 0.01) from 0.60 +/- 0.89 to 0.084 +/- 0.305 times/patient. year after anti-reflux surgery, renal scarring progressed in 13 kidneys (5.8%). Seven of the 13 kidneys became worse due to the surgical failure. The scar progression was recognized in the remaining six kidneys (three patients) including adult cases despite the successful surgical correction of reflux. Our study points to the urged need for a prospective clinical trial designed for the study of the pathological and clinical background of progressive renal failure in VUR.
 ...
PMID:[Vesicoureteral reflux and renal scarring. Report of cooperative study of "Progressive renal disease" of Ministry of Health and Welfare]. 187 71

Renal scarring is in most instances caused by infection in the young child. The most commonly occurring etiological agent in urinary tract infections is Escherichia coli. An important virulence factor for these nephropathogenic E. coli is the ability to adhere to urinary tract epithelium. This adhesion is often mediated by P-fimbriae, which recognize and specifically bind to the receptor structure (alpha-D-Galp-(1-4)beta-D-Galp) present on the cell membranes of human urinary tract epithelium. This carbohydrate structure occurs as an entity of the glycosphingolipids that correspond to the antigens of the human P blood group system. It has been proposed recently that children with recurrent acute pyelonephritis have a higher frequency of the P1 blood group phenotype than the expected 75%. We have studied 56 adult female patients with a history of febrile urinary tract infection and signs of renal scarring on urogram. The P blood group phenotype was determined in all patients. There was no increase of the P1 blood group phenotype in the patients with verified renal scarring. In conclusion, our results do not support a role of the P1 blood group phenotype in the pathogenesis of renal scarring due to previous febrile urinary tract infection.
 ...
PMID:Lack of correlation of P blood group phenotype and renal scarring. 408 93

Renal scarring, which occurs following refluxing pyelonephritis, is considered to be involved in the development of reflux nephropathy. Prevention of renal scar formation requires immediate initiation of antimicrobial treatment; treatment delay results in renal scarring. We demonstrate that Ebselen, an antioxidant agent, given at a dose of 15 mg/kg twice a day prevents renal scarring in rats following direct renal parenchymal bacterial inoculation. In addition, using an ascending pyelonephritis model, which clinically resembles refluxing pyelonephritis in humans, we show that when initiation of antimicrobial treatment was delayed, coadministration of Ebselen prevents renal scar formation. These results show that Ebselen is effective in preventing renal scarring and suggest that the clinical use of this drug may prevent renal scar formation following pyelonephritis and progression to reflux nephropathy.
 ...
PMID:Effect of ebselen on renal scarring in rats following renal infection. 765 68

The histories and imaging results are presented in 10 children in whom errors had been made in the interpretation of early investigations. Ultrasonography may not detect either vesicoureteric reflux (VUR) or renal scars or inflammation. The reduced nephrogram or renal swelling following a first attack of acute pyelonephritis may not be recognised without renal measurement on an intravenous urogram. Renal scarring may be diagnosed incorrectly on the basis of functional defects of isotope uptake on a technetium 99m-dimercaptosuccinic acid study. In the absence of VUR, the micturating cystogram will not visualise the kidneys.
 ...
PMID:Pitfalls in the investigation of children with urinary tract infection. 774 79

Renal scarring is considered to be a characteristic of reflux nephropathy. The effects of ulinastatin, a strong inhibitor of polymorphonuclear leukocyte elastase, on renal scarring following direct parenchymal or intravesical ascending infection by Serratia marcescens or Escherichia coli were determined. Four days of treatment with ulinastatin initiated 2 or 5 days after infection prevented renal scarring. Doses of 1,000-4,000 units/kg inhibited renal scar formation, but 8,000 units/kg did not. These results suggest that it may be possible to limit renal scar formation in pyelonephritis by the use of an appropriate pharmacologic agent.
 ...
PMID:Preventive effect of ulinastatin on renal scarring in rat model of pyelonephritis induced by direct or ascending infection with Serratia marcescens or Escherichia coli. 789

Renal scarring is considered to develop in the later stages of chronic pyelonephritis. In our experimental model of pyelonephritis, bacteria with mannose-sensitive (MS) pili on their surface promoted renal scarring following inoculation into the renal parenchyma. The administration of cyclophosphamide to induce leukopenia and of superoxide dismutase to inactivate superoxide released from polymorphonuclear leukocytes (PMN) at the infection site suppressed any renal scarring following the infection. Conversely, the administration of phorbol myristate acetate at an early stage of infection significantly enhanced the renal scarring. These findings suggest that the PMNs which infiltrate the infection site and the superoxide they release play an important role in any renal scarring following infection with MS-piliated bacteria.
 ...
PMID:Renal scarring is enhanced by phorbol myristate acetate following infection with bacteria with mannose-sensitive pili. 793 44

Seventy six children, 18 boys and 58 girls, aged 0-15.9 (median 1.0) years, with acute pyelonephritis were prospectively studied with a technetium-99m dimercaptosuccinic acid (DMSA) scan during infection and two months later. Fifty nine of these children were also studied two years after the infection. Seventeen children with a normal DMSA scan during infection or at two months after infection, or both, were not investigated by a DMSA scan at two years after acute pyelonephritis. A micturition cystourethrogram was performed in all the children after two months. Changes on the DMSA scan were found in 65 (86%) children during acute pyelonephritis, in 45 (59%) children at two months, and in 28 (37%) children at two years after infection. Vesicoureteric reflux (VUR) was found in 19 (25%) children at two months. Renal scarring was significantly correlated with the presence of gross VUR and recurrent pyelonephritis, but 62% of the scarred kidneys were drained by non-refluxing ureters. Children with scars were older at the time of acute pyelonephritis than those without scars but no difference was found between the groups with regard to duration of illness, levels of C reactive protein and maximum white cell count, glomerular filtration rate, nor renal concentration capacity at the time of infection. It is concluded that renal scarring after acute pyelonephritis in children is more common than has been previously thought. Although children with gross VUR and recurrent pyelonephritis are at the greatest risk, renal scarring is more often seen without these risk factors.
 ...
PMID:Renal scarring after acute pyelonephritis. 797 42

Renal scarring is considered a criterion of reflux nephropathy and the end stage of pyelonephritis. Prednisolone, a strong anti-inflammatory drug, at doses of 1 or 2 mg/kg prevented renal scarring in rats following infection with Serratia marcescens. Four or 8 mg/kg of prednisolone, however, did not inhibit renal scar formation. In a time course experiment, renal scarring was prevented when 4-day treatment with prednisolone was initiated 2, 5, or 13 days after infection. These results show that prednisolone is effective in preventing such scarring and suggest the clinical use of this drug for preventing renal scar formation after pyelonephritis and reflux nephropathy.
 ...
PMID:Effect of prednisolone on renal scarring in rats following infection with Serratia marcescens. 829 Jul 1

Scintigraphic evaluation of urinary tract infection, pyelonephritis, and renal scarring represents a significant portion of a clinical pediatric nuclear medicine practice. Renal scarring from recurring infection remains an important cause of end-stage renal disease and hypertension in the pediatric population. However, the clinical presentation in infants and young children is often elusive, and clinical diagnosis of upper tract involvement is frequently unreliable. As a result, diagnostic imaging has a critical role to play in the localization of infection to the lower or upper urinary tract. Radionuclide cystography and renal cortical imaging have become mainstays of this evaluation. Direct radionuclide cystography is the preferred cystographic screening technique, because it has lower radiation exposure and greater sensitivity for the detection of vesicoureteral reflux than either indirect radionuclide cystography or fluoroscopic contrast cystography. Renal cortical scintigraphy has become the standard for the detection of pyelonephritis and renal scarring. Correlation with histopathology has demonstrated a high degree of diagnostic accuracy. Acute pyelonephritis has been shown to be the necessary etiologic factor for the development of subsequent renal scarring, and the mechanism of renal injury in pyelonephritis has been extensively studied in experimental models. The ability of prompt and appropriate antibiotic therapy to dramatically reduce the incidence of subsequent scarring also has been conclusively demonstrated both clinically and in the experimental model. Vesicoureteral reflux was once thought to be a necessary prerequisite for the development of renal scarring. Although it is clear that the intrarenal reflux of infected urine will create pyelonephritis in the experimental model, the high incidence of pyelonephritis and subsequent scarring in the absence of demonstrable vesicoureteral reflux leaves the role of reflux in question. Although the role of vesicoureteral reflux is incompletely understood, its detection nevertheless remains a standard part of the patient's evaluation.
 ...
PMID:Scintigraphic evaluation of pediatric urinary tract infection. 837 94

Renal scarring has been thought to occur in the later stages of chronic pyelonephritis. We previously reported that mannose-sensitive (MS) piliated bacteria promoted renal scarring, which was prevented by antioxidants. The preventive effect of diaphenylsulfone (dapsone), which has a scavenging activity on active oxygen species, on renal scarring was examined. Female Sprague-Dawley rats were inoculated with clinical isolates of Serratia marcescens which had both MS and mannose-resistant pili or with recombinant strains which had MS pili on their surface; they were then administered 20 mg/kg of dapsone or not. Dapsone significantly suppressed scarring following infection of the kidney. The bacterial counts in the kidneys were not different in dapsone-treated and nontreated rats. We conclude that dapsone is effective in preventing renal scarring, and it is suggested that the clinical use of this drug may prevent renal scar formation following pyelonephritis.
 ...
PMID:Preventive effect of dapsone on renal scarring following mannose-sensitive piliated bacterial infection. 1040 27


1 2 Next >>